fMRI-Directed rTMS Targeting V1 Alleviates Depressive Symptoms in Young Individuals with Bipolar Disorder: Results from a Double-Blind Randomized Controlled Study - Report - MDSpire

fMRI-Directed rTMS Targeting V1 Alleviates Depressive Symptoms in Young Individuals with Bipolar Disorder: Results from a Double-Blind Randomized Controlled Study

  • By

  • Xudong Zhao

  • Hetong Zhou

  • Xiaomei Zhang

  • Ruoyu Tang

  • Yimei Gan

  • Tongjie Zhuang

  • Yiyi Zhu

  • Zeyu Qin

  • Yiqing Chen

  • Yaoyang Fu

  • Danhua Zhang

  • Le Xu

  • Shiliang Wang

  • Zhongxia Shen

  • Shaohua Hu

  • Minmin Wang

  • March 7, 2026

  • 0 min

Share

Clinical Report: fMRI-Directed rTMS Targeting V1 Alleviates Depressive Symptoms

Overview

{'age_range': "Specify the age range of 'young individuals' (e.g., 12-25 years)."}

Background

{'statistics': 'Include specific statistics or references regarding the management challenges of depressive symptoms in bipolar disorder.'}

Data Highlights

{'numerical_values': 'Add numerical values for the changes in MADRS scores at week 3 and week 8.'}

Key Findings

{'magnitude': 'Include the specific percentage or point reduction in MADRS scores.'}

Clinical Implications

{'side_effects': 'Discuss potential side effects or limitations of rTMS.'}

Conclusion

{'future_research': 'Propose specific areas for further exploration in clinical practice.'}

References

  1. BMC Psychiatry (Springer), 2025 -- Impact of Enhanced Intermittent Theta Burst Stimulation on Depressive Symptoms and Cognitive Abilities in Adolescents with Bipolar Disorder
  2. BMC Psychiatry (Springer), 2025 -- Characterising resting motor threshold in depressed individuals across life span: a large retrospective study
  3. Frontiers in Psychiatry, 2026 -- Exploring the Efficacy of Low-Frequency Transcranial Magnetic Stimulation for Sensory and Behavioral Improvements in Pediatric Autism Spectrum Disorder: A Randomized Study
  4. Consensus review and considerations on TMS to treat depression, ScienceDirect, 2024
  5. Danish Psychiatric Society’s 2025 TMS guideline
  6. BMC Psychiatry (Springer) — Neural Network Associations with Response Inhibition Linked to Antidepressant Efficacy in Major Depressive Disorder
  7. NeuroStar® Advanced Therapy Receives FDA Clearance as a First-Line Add-On Treatment for Adolescents with Depression
  8. Defining Treatment‐Resistant Bipolar Depression: Recommendations From the ISBD Task Force
  9. Consensus review and considerations on TMS to treat depression: A comprehensive update endorsed by the National Network of Depression Centers, the Clinical TMS Society, and the International Federation of Clinical Neurophysiology - ScienceDirect
  10. TMS GUIDELINES
  11. Accelerated Intermittent Theta-Burst Stimulation and Treatment-Refractory Bipolar Depression: A Randomized Clinical Trial - PMC
  12. Efficacy and safety of repetitive transcranial magnetic stimulation in youth with depression: a systematic review and meta-analysis of randomized sham-controlled trials - PMC
  13. Effectiveness of personalized repetitive transcranial magnetic stimulation for major depressive disorder: A systematic review and meta-analysis of randomized active-controlled trials - ScienceDirect
  14. A Systematic Review and Meta-Analysis of Randomized Sham-Controlled Trials of Repetitive Transcranial Magnetic Stimulation for Bipolar Disorder | Psychiatric Quarterly

Original Source(s)

Related Content